Bio-Bridge Science Receives Business License For Bio-Bridge JRS

Bio-Bridge Science has received a business license from the Beijing Administration for Industry and Commerce of the People’s Republic of China (PRC) indicating approval of the formation of Bio-Bridge JRS Biosciences (Beijing) (Bio-Bridge JRS).

Bio-Bridge JRS, is located in Beijing, China, and is expected to produce cell culture medium and related biomaterials for use in scientific research and vaccine production.

The company said that Bio-Bridge JRS will complement Bio-Bridge Science’s previous acquisition of Xinheng Baide Biotechnology, by strengthening the company’s vaccine-related biomaterials supplier in the PRC.

Liang Qiao, chairman and CEO of Bio-Bridge Science, said: “We are pleased to receive the business license indicating approval of the formation of Bio-Bridge JRS by the Beijing City government of the PRC. We expect Bio-Bridge JRS to provide Bio-Bridge Science with an additional source of revenue, diversified product offerings, as well as, cell culture medium and bio-materials for use in our internal vaccine development.”